ArticleOdontology2026
Multifunctional aloe vera-based biomaterial for vital pulp therapy: an in vivo evaluation.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study aimed to evaluate the effects of Gelatin methacryloyl/Aloe vera (GelMA/AV) scaffolds, both alone and in combination with mineral trioxide aggregate (MTA), on pulp inflammatory response and mineralized tissue formation in a rat model of pulp exposure. GelMA/AV nanofibers (70:30) were fabricated via electrospinning and photocrosslinked. Twenty-four rats were randomly assigned to three groups (n = 8/ group): GelMA/AV, GelMA/AV + MTA, and MTA (control). Following pulp exposure of the first upper molars (n = 2/animal), the materials were placed over the exposed pulp as the pulp capping agent, and MTA was applied or not, depending on the group. The cavities were then sealed with glass ionomer. Animals were euthanized at 7 or 28 days post-procedure for histological, immunohistochemical, and micro-computed tomography (micro-CT) analyses. Data were analyzed using one-way or two-way ANOVA at a 5% significance level. Micro-CT analysis at 28 days revealed new hard tissue formation in the pulp chamber across all groups. GelMA/AV + MTA demonstrated comparable mineralized volume and tissue mineral density to MTA. Histologically, the GelMA/AV + MTA group exhibited a significantly lower cell count than the MTA and GelMA/AV groups at 28 days. However, for macrophage polarization, the GelMA/AV + MTA exhibited a similar expression of CD163-positive (M2) and iNOS-positive (M1) cells compared to the MTA. Lastly, GelMA/AV + MTA also showed expression of nestin and DMP1 at 28 days, indicating active mineralization. In conclusion, a thin GelMA/AV sublayer beneath MTA preserves MTA-driven mineralization but does not reduce pulp inflammation or enhance mineralization beyond MTA in this model. Optimization of AV dosing/formulation and longer follow-up are necessary before clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.